|Day's Range||0.115 - 0.125|
|52 Week Range||0.100 - 0.250|
|PE Ratio (TTM)||-2.45|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
TORONTO, ON / ACCESSWIRE / June 12, 2017 / Kane Biotech Inc. (TSX-V: KNE, OTC PINK: KNBIF) will be presenting at this year's MicroCap Conference on June 27 th in Toronto. CONFERENCE OVERVIEW AND STRUCTURE ...
Kane Biotech Inc. today announced the intention of the Company to undertake a non-brokered private placement offering of up to 33,333,333 units at a price of $0.12 per Unit for gross proceeds of up to ...
Kane Biotech Inc. is pleased to announce its Q1 2017 Financial Results.